Pune, India, 2022 /MRFR Press Release/- Market Research Future has a cooked research report on the global anti-ageing drugs market.
Anti Ageing Drugs Market Highlights
According to Market Research Future (MRFR)’s assessment, the Anti Ageing Drugs Market is expected to reach USD 83.39 Billion by 2032 at 6.9% CAGR during the forecast period 2024-2032. The high beauty standards set by the media industry has its influence over all age groups. It has paved the way for the proliferation of anti-ageing drugs market. Furthermore, the key players are also emphasizing on catering to the needs of the male population. This, in turn, is projected to have a positive impact on the growth of the market.
The market is at its nascent stage which makes it lucrative for the new entrants. Investments in research and development activities are poised to grow in the upcoming years. The constant addition of new products to the portfolios coupled with rising awareness is anticipated to aid the proliferation of the anti-ageing drugs market. However, the availability of counterfeit products remains an impediment to market growth.
Market Segmentation:
On the basis of drug class, the global anti-ageing drugs market has been segmented into serums and supplements, antioxidants and enzymes, stem cells and drugs.
On the basis of application, the anti-ageing drugs market has been segmented into skin and hair, skeletal and muscles, age-related disorders and others.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Anti Ageing Drugs Market Research Report
Regional Insights:
The global anti-ageing drugs market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas houses developed and influential economies such as the U.S. and Canada. It is projected to favor the market growth in the region. In addition, the influence of Hollywood in setting beauty standards have affected all the age groups alike. This has paved the way for the expansion of the anti-ageing drugs market in the region.
Europe is also a promising market and is likely to exhibit a similar trend as that of the Americas’. It is expected to secure the second spot in the global anti-ageing drugs market.
Asia Pacific is projected to thrive at a comparatively higher CAGR of 15.3% over the assessment period. The growth of the personal care industry in fast-developing economies such as South Korea, Japan, India, and China among others. In addition, the contribution of the male population towards the expansion of the anti-ageing drugs market is likely to revolutionize its future trajectory.
The Middle Eastern countries such as Saudi Arabia and the U.A.E have emerged as the shopping hubs and attract a massive population of tourists every year. This is poised to aid the proliferation of the anti-ageing drugs market in the region over the next couple of years.
Competitive Dashboard:
The prominent players identified in this MRFR report are DermaFix, Nu Skin, Elysium Health Inc., BIOTIME, INC., La Roche-Posay, and L'ORÉAL.
Industry News:
In January 2019, Evine Live Inc., a multiplatform interactive video and digital commerce company, announced the debut of Serious Skincare on its network. Eleven items were sold out during the premiere including Anti-Aging Retinol Serum Duo and Reverse Uplift Kit.
In December 2018, Nuxe, a leading French natural cosmetics brand has announced the launch of Nuxuriance Gold collection, which includes anti-ageing skincare products, into global travel retail.
In October 2018, Germany-based Lidl has added a new intensive anti-ageing serum to its Q10 beauty range.
In September 2018, SkinCeuticals, which is a leader in advanced skincare technology, has announced the addition of Retinol 0.3, a new anti-aging retinol cream, to its portfolio.
In August 2018, Poundland, a British variety store chain, has announced the launch of its new anti-ageing skincare range.
In April 2018, No7’s, a high street beauty brand, has introduced its new Laboratories Line Correcting Booster Serum which is claimed to offer better results than Botox.